Bruker Corporation (BRKR)

CIK 0001109354 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-04) · 99.1
Q1-2026 8-K (2026-05-06) · 99.1
Latest FY-2025 8-K (2026-02-12) · 99.1  |  8-K (2026-01-12)
Q3-2025 8-K (2025-11-03) · 99.1
Q2-2025 8-K (2025-08-04) · 99.1  |  8-K (2025-07-21) · 99.1
Q1-2025 8-K (2025-05-07) · 99.1  |  8-K (2025-04-11) · 99.1
FY-2024 8-K (2025-02-13) · 99.1  |  8-K (2025-01-13)
Q3-2024 8-K (2024-11-05) · 99.1
Q2-2024 8-K (2024-08-06) · 99.1
Q1-2024 8-K (2024-05-02) · 99.1
FY-2023 8-K (2024-02-13) · 99.1  |  8-K (2024-01-08)
Q3-2023 8-K (2023-11-02) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Statements
Consolidated Balance Sheets
—
Unaudited Condensed Consolidated Balance Sheets
—
Consolidated Balance Sheets (P)
—
Unaudited Condensed Consolidated Balance Sheets (P)
—
Unaudited Condensed Consolidated Statements of Operations
—
Consolidated Statements of Operations
—
Statement
—
Unaudited Condensed Consolidated Statements of Comprehensive (loss) Income
—
Unaudited Condensed Consolidated Statements of Comprehensive Income
—
Unaudited Condensed Consolidated Statements of Income
—
Unaudited Condensed Consolidated Statements of Income and Comprehensive Income
—
Consolidated Statements of Comprehensive (loss) Income
—
Consolidated Statements of Comprehensive Income
—
Unaudited Condensed Consolidated Statements of Comprehensive Income (loss)
—
Unaudited Condensed Consolidated Statements of Redeemable Noncontrolling Interests and Shareholders' Equity
—
Unaudited Consolidated Statements of Comprehensive Income
—
Consolidated Statements of Comprehensive Income (P)
—
Consolidated Statements of Redeemable Noncontrolling Interests and Shareholders' Equity
—
Unaudited Condensed Consolidated Statements of Cash Flows
—
Unaudited Condensed Consolidated Statements of Comprehensive Income (loss)(P)
—
Unaudited Consolidated Statements of Comprehensive Income (P)
—
Consolidated Statements of Redeemable Noncontrolling Interests and Shareholders' Equity (P)
—
Unaudited Condensed Consolidated Statements of Redeemable Noncontrolling Interest and Shareholders' Equity (P)
—
Consolidated Statements of Cash Flows
—
Notes
Accounts Receivable,net
—
Acquisitions
Allowance For Doubtful Accounts
—
Business Segment Information
Commitments and Contingencies
Contingent Consideration
Cybersecurity Risk Management, Strategy and Governance
—
Debt
Derivative and Designated Hedging Instruments
—
Derivative Instruments and Hedging Activities
Derivative Instruments and Hedging Instruments
—
Description of Business
Earnings (loss) Per Share
Earnings Per Share
Fair Value of Financial Instruments
Goodwill and Intangible Assets
Hybrid Instruments Liabilities
Income Taxes
—
Insider Trading Arrangements
Interest and Other Expense, Net
—
Interest and Other Income (expense), Net
Inventories
Leases
—
Minority and Equity-method Investments
Other (gains) Charges, Net
—
Other Charges, Net
Other Current and Long-term Assets
—
Other Current and Long-term Liabilities
—
Other Current Assets
Other Current Liabilities
—
Pay Vs Performance Disclosure
Post Retirement Benefit Plans
—
Post-retirement Benefit Plans
—
Property, Plant and Equipment, Net
—
Provision For Income Taxes
—
Recent Accounting Pronouncements
Restructuring
Restructuring and Asset Impairments
Revenue
Shareholders' Equity
Subsequent Events
Summary of Significant Accounting Policies
—
Weighted Average Shares Outstanding
—